Sentence examples for dynamic cancer from inspiring English sources

As the dynamic cancer topography varies drastically during disease progression, heterologous cell types within the tumor microenvironment (TME) can actively determine the pathological track of ovarian cancer.

One may imagine a sequence of metastatic events in a patient as a trajectory on this dynamic cancer metastasis network.

For the first time, the SIG method combines gene co-expression pattern change study with the concept of dynamic cancer progression.

Pan-cancer analysis revealed that while strength of ceRNA regulation is dynamic across cancer types, the highly intertwined ceRNA signaling stably maintains the essential functions it governs.

Consequently, our study underscores the uniqueness of individual cancers, dynamic tracking of cancer progression and new therapy strategies targeting the entire cell system.

By adopting a side-coupling cavity design to avoid the oscillation, we have developed 6 MeV X-band (9.3 GHz) linac for pinpoint dynamic tracking cancer therapy.

Incorporating these observations, we concluded that while the strength of ceRNA regulation is dynamic across cancer types, the essential biological functions governed by ceRNA regulation are stably retained.

Furthermore, although the strength of ceRNA regulation is dynamic among cancers, its governing functions are stably maintained.

And the dynamic process of cancer development appears to be the reason that screening for breast cancer or prostate cancer finds huge numbers of early cancers without a corresponding decline in late stage cancers.

The cracks in the paradigm of oncogenic mutations and somatic evolution as driving force of tumorigenesis, lucidly exposed by the dynamic heterogeneity of "cancer stem cells" or the diffuse results of cancer genome sequencing projects, indicate the need for a more encompassing theory of cancer that reaches beyond the current proximate explanations based on individual genetic pathways.

These findings indicate that in thyroid cancers, the CD133+ and CD133− populations are in dynamic equilibrium during cancer progression.